Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Collapse authors list.
Godman, Brian ORCID: 0000-0001-6539-6972, Hill, Andrew, Simoens, Steven, Kurdi, Amanj, Gulbinovič, Jolanta, Martin, Antony P ORCID: 0000-0003-4383-6038, Timoney, Angela, Gotham, Dzintars, Wale, Janet, Bochenek, Tomasz et al (show 38 more authors) , Rothe, Celia C, Hoxha, Iris, Malaj, Admir, Hierländer, Christian, Sauermann, Robert, Hamelinck, Wouter, Mitkova, Zornitza, Petrova, Guenka, Laius, Ott, Sermet, Catherine, Langer, Irene, Selke, Gisbert, Yfantopoulos, John, Joppi, Roberta, Jakupi, Arianit, Poplavska, Elita, Greiciute-Kuprijanov, Ieva, Vella Bonanno, Patricia, Piepenbrink, JF Hans, de Valk, Vincent, Hagen, Carolin, Ringerud, Anne Marthe, Plisko, Robert, Wladysiuk, Magdalene, Marković-Peković, Vanda, Grubiša, Nataša, Ponorac, Tatjana, Mardare, Ileana, Novakovic, Tanja, Parker, Mark, Fürst, Jurij, Tomek, Dominik, Cortadellas, Mercè Obach, Zara, Corinne, Juhasz-Haverinen, Maria, Skiold, Peter, McTaggart, Stuart and Haycox, Alan (2019) Pricing of oral generic cancer medicines in 25 European countries; findings and implications. Generics and Biosimilars Initiative Journal, 8 (2). 49 - 70.

Text Accepted publication Godman et al.docx - Accepted Version Download (343kB)